Cantor Fitzgerald raised Microsoft's price target from $522 to $608, implying higher expected value; the analyst kept an Overweight rating.
A Cantor Fitzgerald price-target lift raises the reference investors use for Microsoft and supports a more positive view. The firm kept an Overweight rating, reinforcing that signal despite a small market dip.
Freedom Capital Markets raised Inspire Medical's price target from $71 to $97 and kept a Buy rating, which signals stronger analyst expectations.
Rosenblatt raised Securitize's price target from $11 to $13 and kept a Buy rating, which indicates higher analyst valuation.
GLJ Research raised Cleveland-Cliffs' price target from $15.6 to $17.48 and kept a Buy rating, raising analyst expectations for the company.
Mizuho cut Credo Technology's price target from $290 to $245, lowering the analyst's valuation view despite keeping an Outperform rating.
Piper Sandler trimmed Colgate-Palmolive's price target from $98 to $95, which reduces analyst expectations even as the rating stayed Overweight.
Follow Microsoft Corporation (MSFT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MSFT